Related scientific articles (all)

Response to 'Is it safe to perform a controlled ovarian stimulation for assisted reproduction in young breast cancer survivors?'

Authors : Goldrat O, Demeestere I, Azim HA
Year : 2016
Journal : Eur J Cancer
Volume : 54
Pages : 165-6

Biomarkers for adverse events associated with immune checkpoint inhibitors.

Authors : Kourie HR, Paesmans M, Klastersky J
Year : 2016
Journal : Biomark Med
Volume : 10
Pages : 1029-31

Ex vivo detection of tumoral lymph nodes of colorectal origin with fluorescence imaging after intraoperative intravenous injection of indocyanine green.

Authors : Liberale G, Gomez Galdon M, Moreau M, Vankerckhove S, El Nakadi I, Larsimont D, Donckier V, Bourgeois P
Year : 2016
Journal : J Surg Oncol
Volume : 114(3)
Pages : 348-53

L'euthanasie et la gestion de fin de vie: un débat éthique permanent.

Authors : Berghmans T
Year : 2016
Journal : Rev Med Brux
Volume : 37(2)
Pages : 69

The potential of mesenchymal stromal cells in immunotherapy.

Authors : Fayyad-Kazan M, Fayyad-Kazan H, Lagneaux L, Najar M
Year : 2016
Journal : Immunotherapy
Volume : 8
Pages : 839-42

GLI inhibitor GANT61 kills melanoma cells and acts in synergy with obatoclax.

Authors : Vlckova K, Reda J, Ondrusova L, Krayem M, Ghanem G, Vachtenheim J
Year : 2016
Journal : Int J Oncol
Volume : 49
Pages : 953-60

Rare side-effects of checkpoint inhibitors.

Authors : Kourie HR, Awada G, Awada A
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 295-305

Dispositifs intra-utérins au lévonorgestrel et risque de cancer du sein ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer.

Authors : Twelves C, Awada A, Cortes J, Yelle L, Velikova G, Olivo MS, Song J, Dutcus CE, Kaufman PA
Year : 2016
Journal : Breast Cancer (Auckl)
Volume : 10
Pages : 77-84

Fever of unknown origin in cancer patients.

Authors : Loizidou A, Aoun M, Klastersky J
Year : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pages : 125-30

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients.

Authors : Lambertini M, Pinto AC, Ameye L, Jongen L, Del Mastro L, Puglisi F, Poggio F, Bonotto M, Floris G, Van Asten K, Wildiers H, Neven P, de Azambuja E, Paesmans M, Azim HA Jr
Year : 2016
Journal : Br J Cancer
Volume : 115(12)
Pages : 1471-78

Testicular germ cell tumor: Short and long-term side effects of treatment among survivors.

Authors : Gil T, Sideris S, Aoun F, Van Velthoven R, Sirtaine N, Paesmans M, Ameye L, Awada A, Devriendt D, Peltier A
Year : 2016
Journal : Mol Clin Oncol
Volume : 5
Pages : 258-264

Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: Is ignorance a Bliss?

Authors : Tabchi S, El Rassy E, Khazaka A, El Karak F, Kourie HR, Chebib R, Assi T, Ghor M, Naamani L, Richa S, Ghosn M, Kattan J
Year : 2016
Journal : Qual Life Res
Volume : 25
Pages : 1597-604

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.

Authors : Bottai G, Raschioni C, Losurdo A, Di Tommaso L, Tinterri C, Torrisi R, Reis-Filho JS, Roncalli M, Sotiriou C, Santoro A, Mantovani A, Loi S, Santarpia L
Year : 2016
Journal : Breast Cancer Res
Volume : 18
Pages : 121

Les patients rapportent-ils mieux les effets toxiques subjectifs de la chimiothérapie anticancéreuse que les médecins ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

Y a-t-il un rôle pour les nouveaux anticoagulants oraux dans le traitement à long terme de l’embolie pulmonaire ?

Authors : Sculier JP
Year : 2016
Journal : Minerva.ebm
Volume : 15(7)
Pages : 170-4

Supportive/palliative care in cancer patients: quo vadis?

Authors : Klastersky J, Libert I, Michel B, Obiols M, Lossignol D
Year : 2016
Journal : Support Care Cancer
Volume : 24(4)
Pages : 1883-8

Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?

Authors : Morgan G, Aftimos P, Awada A
Year : 2016
Journal : Curr Opin Oncol
Volume : 28(5)
Pages : 441-6

Impact of dermatologic adverse events induced by targeted therapies on quality of life.

Authors : Charles C, Bungener C, Razavi D, Mateus C, Routier E, Lanoy E, Verschoore M, Robert C, Dauchy S
Year : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pages : 158-68

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Authors : Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu B, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP
Year : 2016
Journal : Breathe (Sheff)
Volume : 12
Pages : 249-255